Keyur Desai

546 total citations
28 papers, 318 citations indexed

About

Keyur Desai is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Keyur Desai has authored 28 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Keyur Desai's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and CAR-T cell therapy research (7 papers). Keyur Desai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and CAR-T cell therapy research (7 papers). Keyur Desai collaborates with scholars based in United States, United Kingdom and Italy. Keyur Desai's co-authors include Michael J. Gerdes, Lila Solnica‐Krezel, Anne E. Powell, Haiting Ma, Cunxi Li, Robert J. Coffey, Ramona Graves‐Deal, Gregory D. Ayers, Yang Wang and Vidya Kamath and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Keyur Desai

27 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyur Desai United States 9 149 137 56 53 51 28 318
Yukihiro Shiraki Japan 11 165 1.1× 135 1.0× 32 0.6× 30 0.6× 63 1.2× 29 354
Zhao Liu China 12 136 0.9× 82 0.6× 100 1.8× 43 0.8× 49 1.0× 29 301
Natalie L. Lister Australia 9 137 0.9× 148 1.1× 81 1.4× 26 0.5× 111 2.2× 12 364
Rocío Granda‐Díaz Spain 12 182 1.2× 174 1.3× 48 0.9× 33 0.6× 66 1.3× 20 374
Qingjie Min China 9 212 1.4× 68 0.5× 45 0.8× 25 0.5× 31 0.6× 12 301
Maria Liousia United States 11 122 0.8× 236 1.7× 74 1.3× 26 0.5× 119 2.3× 16 412
Keith Wells United States 7 184 1.2× 187 1.4× 36 0.6× 27 0.5× 73 1.4× 11 364
Yiannis Drosos United States 10 154 1.0× 135 1.0× 17 0.3× 49 0.9× 48 0.9× 13 282
Cláudia Miranda Italy 11 223 1.5× 143 1.0× 72 1.3× 24 0.5× 37 0.7× 15 411

Countries citing papers authored by Keyur Desai

Since Specialization
Citations

This map shows the geographic impact of Keyur Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyur Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyur Desai more than expected).

Fields of papers citing papers by Keyur Desai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyur Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyur Desai. The network helps show where Keyur Desai may publish in the future.

Co-authorship network of co-authors of Keyur Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Keyur Desai. A scholar is included among the top collaborators of Keyur Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyur Desai. Keyur Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chow, Tracy T., Nicholas Stong, Chad C. Bjorklund, et al.. (2024). Biomarker Analyses of the CC-92480-MM-001 Trial to Guide Combinatorial Strategies for Mezigdomide. Blood. 144(Supplement 1). 3261–3261. 1 indexed citations
2.
Thompson, Ethan, Julia Piasecki, Paula Rodríguez‐Otero, et al.. (2024). Association of patient (pt) factors and pharmacodynamic biomarkers with progression-free survival (PFS) after idecabtagene vicleucel (ide-cel) in pts from KarMMa-3.. Journal of Clinical Oncology. 42(16_suppl). 7527–7527. 2 indexed citations
3.
Wiggins, Jennifer, Hao Tang, Keyur Desai, et al.. (2023). Association of circulating tumor DNA kinetics with disease recurrence in patients with stage IIIB/C/IV melanoma treated with adjuvant immunotherapy in Checkmate 238.. Journal of Clinical Oncology. 41(16_suppl). 9577–9577. 3 indexed citations
4.
5.
6.
Wojcik, John, et al.. (2023). Measurement of LAG-3 Expression Across Multiple Staining Platforms With the 17B4 Antibody Clone. Archives of Pathology & Laboratory Medicine. 147(11). 1307–1314. 1 indexed citations
7.
8.
9.
Lee, George, Keyur Desai, Hao Tang, et al.. (2021). 387 The utility of AI-powered spatial classification of intratumoral CD8+ immune-cell distribution in predicting overall survival in patients with melanoma as part of the checkMate 067 clinical trial. Journal for ImmunoTherapy of Cancer. 9(Suppl 2). A420–A420. 2 indexed citations
10.
Li, Bin, Lloye M. Dillon, Jennifer L. Jones, et al.. (2020). A comparative study of PD-L1 IHC assays using immune cell scoring and CPS in breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e15262–e15262. 3 indexed citations
11.
Qi, Zhenhao, Lisu Wang, Keyur Desai, et al.. (2019). Reliable Gene Expression Profiling from Small and Hematoxylin and Eosin–Stained Clinical Formalin-Fixed, Paraffin-Embedded Specimens Using the HTG EdgeSeq Platform. Journal of Molecular Diagnostics. 21(5). 796–807. 17 indexed citations
12.
Leontovich, Alexey A., Michael J. Gerdes, Keyur Desai, et al.. (2019). Understanding heterogeneous tumor microenvironment in metastatic melanoma. PLoS ONE. 14(6). e0216485–e0216485. 34 indexed citations
13.
Desai, Keyur, et al.. (2017). Extra-adrenal pheochromocytoma at the organ of Zuckerkandl: a case report and literature review. Radiology Case Reports. 12(2). 343–347. 6 indexed citations
14.
Desai, Keyur, et al.. (2017). Lemmel Syndrome Secondary to Duodenal Diverticulitis: A Case Report. Cureus. 9(3). e1066–e1066. 34 indexed citations
15.
Li, Cunxi, Haiting Ma, Yang Wang, et al.. (2014). Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer. Journal of Clinical Investigation. 124(5). 2172–2187. 99 indexed citations
16.
Desai, Keyur, Imran Chaudhary, Mohammad H. Ghalib, et al.. (2007). Pharmacodynamic and safety study of reolysin in patients with advanced solid tumors. Journal of Clinical Oncology. 25(18_suppl). 14004–14004. 4 indexed citations
17.
Villalona‐Calero, Miguel A., Swati Goel, Larry J. Schaaf, et al.. (2006). First-in-human phase I trial of a novel epothilone, KOS-1584. Journal of Clinical Oncology. 24(18_suppl). 2003–2003. 17 indexed citations
18.
Goel, Sanjay, Keyur Desai, Dominik Verdier-Pinard, et al.. (2004). A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies. Journal of Clinical Oncology. 22(14_suppl). 2113–2113. 1 indexed citations
19.
Keithley, Elizabeth M., et al.. (2001). Mitochondrial cytochrome oxidase immunolabeling in aged human temporal bones. Hearing Research. 157(1-2). 93–99. 13 indexed citations
20.
Desai, Keyur, Catherine Brady, Julie M. Williams, et al.. (2001). Generation of a selective 5-HT3B subunit-recognising polyclonal antibody; identification of immunoreactive cells in rat hippocampus. Neuropharmacology. 41(8). 1013–1015. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukihiro Shiraki Breakdown of academic impact, for papers by Zhao Liu Breakdown of academic impact, for papers by Natalie L. Lister Breakdown of academic impact, for papers by Rocío Granda‐Díaz Breakdown of academic impact, for papers by Qingjie Min Breakdown of academic impact, for papers by Maria Liousia Breakdown of academic impact, for papers by Keith Wells Breakdown of academic impact, for papers by Yiannis Drosos Breakdown of academic impact, for papers by Cláudia Miranda
Rankless by CCL
2026